Skip to main content
Premium Trial:

Request an Annual Quote

HHMI, EMBO to Offer 3-Year, $75,000 Grants to Young Investigators in Central Europe

NEW YORK, Feb. 10 (GenomeWeb News) - The Howard Hughes Medical Institute and the European Molecular Biology Organization will accept applications this week for the first of their annual $75,000 grants, which aim to encourage young scientists to establish laboratories in Central Europe, the organizations said yesterday.


The 3-year grants EMBO/HHMI Startup Grants are intended to support the acquisition of "equipment, supplies, personnel, space, and time" by scientists setting up in Croatia, Czech Republic, Estonia, Hungary, Poland, and Slovenia, the statement said.


The European Molecular Biology Organization will oversee the grants as part of its Young Investigator Program, and, along with member countries, it will contribute $25,000 per year for three years for a maximum of six grants. The remaining $50,000 for each of the six grants will come from HHMI, which is funding the effort as part of its international scholars program.


Scientists have until Aug. 1 to apply for the grants with research institutes in the participating countries. As part of the grants, applicant institutes are asked to commit to guarantee long-term support of the young investigators.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.